Skip to content

Effect of Baby-CIMT in Infants Younger Than 12 Months

The Efficacy of Constraint Induced Movement Therapy for Babies (Baby-CIMT) in Infants Below 12 Month With Risk of Developing Unilateral Cerebral Palsy, a Study Protocol of a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01864811
Acronym
B-CIMT
Enrollment
35
Registered
2013-05-30
Start date
2012-09-30
Completion date
2017-12-01
Last updated
2018-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy, Children, Hemiplegia

Keywords

infants, unilateral cerebral pares, hand function, early intervention, constraint induced movement therapy

Brief summary

A randomized control trial investigating if an early intervention program of modified Constraint Induced Movement Therapy for babies, Baby-CIMT, performed before 12 months of age will improve hand function in children with risk for developing cerebral palsy.

Detailed description

The investigators hypothesis is that Baby-CIMT including intensive specific task oriented training is more preferable than general stimulation which is the assumption for baby massage used in the control group. The intervention protocol is developed at Astrid Lindgren Children hospital, Stockholm Sweden.

Interventions

BEHAVIORALBaby-CIMT

Baby-CIMT is a very much modified model of constraint induced movement therapy for infants. It is developed to suit small children and their needs of stimulation. The infant should wear a comfortable glove on the less affected hand, while stimulating the use of the affected hand 30 minutes per day during 2 periods of 6-weeks training before 12 month. The hand training provides the baby with amusing and easily handled toys.

BEHAVIORALBaby-Massage

For baby massage, there will be a special instructional course by a health professional certified for baby massage. Massage should be given every day during 2 periods of 6 weeks. Families will be responsible for the massage.

Sponsors

Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
3 Months to 8 Months
Healthy volunteers
No

Inclusion criteria

1. A neonatal history of different origin of events affecting the brain, preterm children with predominantly unilateral hemorrhage, venous infarction or with matter lesion or pre, perinatal or early postnatal stroke or Infants referred to the hospital/rehabilitation centers/specialists with signs of asymmetries before 8 month of age, likely to be diagnosed with unilateral cerebral palsy at later age. Recruitment criteria of child characteristics * Age can vary, earliest at 3 months of age and at the latest at 8 months * Sign of asymmetries from mild to clear and severe asymmetries,

Exclusion criteria

Severe visual impairment Seizures not controlled by drugs Not unilateral CP at 12 month

Design outcomes

Primary

MeasureTime frameDescription
Hand Assessment for Infants (HAI)12 month post term ageHand Assessment for Infants (HAI) identify and measure upper limb asymmetry and general manual development from 3-12 month in children at risk of developing cerebral palsy.Even though our Primary Outcome Measure is when children are at one year post term age, we are going to publish results from assessments at earlier ages to measure changes after each intervention period.

Secondary

MeasureTime frameDescription
Alberta Motor Infant ScaleBaseline and12 months post term ageIdentification of infants who are delayed or deviant in motor development and evaluation of motor development over time. Identifies gross motor performance of an infant compared to norm- referenced sample.

Other

MeasureTime frameDescription
To Be a Parent: a questionary12 monts post preterm16 statement as both parents has to fill in. they have to agree on the statement based on a 6-grading scale

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026